A comparative analysis of factors influencing two outbreaks of middle eastern respiratory syndrome (MERS) in Saudi Arabia and South Korea

Viruses

Volumn 11, Issue 12, 2019, Pages

  Willman, Marnie ^a,b   Kobasa, Darwyn ^a,b   Kindrachuk, Jason ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Coronavirus; Middle east; Middle east respiratory syndrome (MERS), zoonosis; Saudi Arabia; South Korea

Indexed keywords

CATHEPSIN; CYTOKINE; DECAPENTAPLEGIC PROTEIN; INTERLEUKIN 8; LACTATE DEHYDROGENASE; NUCLEOCAPSID PROTEIN; POLYPROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; AWARENESS; CASE FATALITY RATE; COMPARATIVE STUDY; DEATH; DISEASE TRANSMISSION; ECOLOGY; ENDEMIC DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG FIBROSIS; LUNG LAVAGE; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; ORTHOPOXVIRUS; OUTCOME ASSESSMENT; PLEURA THICKENING; RAPID RESPONSE TEAM; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SAUDI ARABIA; SOCIOLOGICAL THEORY; SOUTH KOREA; ANIMAL; ATTITUDE TO HEALTH; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTION; EPIDEMIC; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PHYSIOLOGY; PROCEDURES; VIROLOGY; ZOONOSIS;

ANIMALS; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; REPUBLIC OF KOREA; SAUDI ARABIA; ZOONOSES;

EID: 85076309194     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v11121119     Document Type: Review

References (65)

1. Zeng, Z.Q.; Chen, D.H.; Tan, W.P.; Qiu, S.Y.; Xu, D.; Liang, H.X.; Chen, M.X.; Li, X.; Lin, Z.S.; Liu, W.K.; et al. Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: A study of hospitalized children with acute respiratory tract infection in Guangzhou China. Eur. J. Clin. Micobiol. Infect. Dis. 2018, 37, 363-369.
2. De Wit, E.; van Doremalen, N.; Falzarano, D.; Munster, V.J. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016, 14, 523-534.
3. Hilgenfeld, R.; Peiris, M. FromSARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir. Res. 2013, 100, 286-295.
4. Wang, L.F.; Shi, Z.; Zhang, S.; Field, H.; Daszak, P.; Eaton, B.T. Review of Bats and SARS. Emerg. Infect. Dis. 2006, 12, 1834-1840.
5. Sikkema, R.S.; Farag, E.A.B.A.; Islam, M.; Atta, M.; Reusken, C.B.E.M.; Al-Hajri, M.M.; Koopmans, M.P.G. Global status of Middle East respiratory syndrome coronavirus in dromedary camels: A systematic review. Epidemiol. Infect. 2019, 147, 84.
6. World Health Organization. Middle East Respiratory Syndrome Coronvirus (MERS-CoV). Available online: https://www.who.int/emergencies/mers-cov/en/ (accessed on 14 April 2019).
7. Kim, K.H.; Tandi, T.E.; Choi, J.W.; Moon, J.M.; Kim, M.S. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: Epidemiology, characteristics and public health implications. J. Hosp. Infect. 2016, 95, 207-213.
8. Faridi, U. Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015. Saudi. J. Biol. Sci. 2018, 25, 1402-1405.
9. Rabaan, A.A.; Bazzi, A.M.; Al-Ahmed, S.H.; Al-Tawfiq, J.A. Molecular aspects of MERS-CoV. Front. Med. 2017, 11, 365-377.
10. Fehr, A.R.; Perlman, S. Coronaviruses: An overview of their replication and pathogenesis. Methods. Mol. Biol. 2015, 1282, 1-23.
11. Yang, Y.; Zhang, L.; Geng, H.; Deng, Y.; Huang, B.; Guo, Y.; Zhao, Z.; Tan, W. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 2013, 4, 951-961.
12. Dawson, P.; Malik, M.R.; Parvez, F.; Morse, S.S. What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review. Vector Borne Zoonotic. Dis. 2019, 19, 174-192.
13. Zhou, Y.; Yang, Y.; Huang, J.; Jiang, S.; Du, L. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain. Viruses 2019, 11, 60.
14. Du, L.; Yang, Y.; Zhou, Y.; Lu, L.; Li, F.; Jiang, S. MERS-CoV spike protein: A key target for antivirals. Expert Opin. Targets 2017, 21, 131-143.
15. Chan, J.F.; Lau, S.K.; To, K.K.; Cheng, V.C.; Woo, P.C.; Yuen, K.Y. Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 2015, 28, 465-522.
16. Shirato, K.; Kawase, M.; Matsuyama, S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J. Virol. 2013, 87, 12552-12561.
17. Lokugamage, K.G.; Narayanan, K.; Nakagawa, K.; Terasaki, K.; Ramirez, S.I.; Tseng, C.T.; Makino, S. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin. J. Virol. 2015, 89, 10970-10981.
18. Virlogeux, V.; Fang, V.J.; Park, M.; Wu, J.T.; Cowling, B.J. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci. Rep. 2016, 6, 35839.
19. Ki, M. 2015 MERS outbreak in Korea: Hospital-to-hospital transmission. Epidemiol. Health 2015, 37, e2015033.
20. Cotten, M.; Watson, S.J.; Zumla, A.I.; Makhdoom, H.Q.; Palser, A.L.; Ong, S.H.; Al Rabeeah, A.A.; Alhakeem, R.F.; Assiri, A.; Al-Tawfiq, J.A.; et al. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio 2014, 5, e01062-13.
21. Van Den Brand, J.M.; Smits, S.L.; Haagmans, B.L. Pathogenesis of Middle East respiratory syndrome coronavirus. J. Pathol. 2015, 235, 175-184.
22. Mackay, I.M.; Arden, K.E. MERS coronavirus: Diagnostics, epidemiology and transmission. Virol. J. 2015, 12, 222.
23. Jevšnik, M.; Uršič, T.; Zigon, N.; Lusa, L.; Krivec, U.; Petrovec, M. Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease. BMC Infect. Dis. 2012, 12, 365.
24. Birch, C.J.; Clothier, H.J.; Seccull, A.; Tran, T.; Catton, M.C.; Lambert, S.B.; Druce, J.D. Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-care facilities in Melbourne, Australia. Epidemiol. Infect. 2005, 133, 273-277.
25. Zaki, A.M.; van Boheemen, S.; Bestebroer, T.M.; Osterhaus, A.D.; Fouchier, R.A. Isolation of a Novel Coronavirus from aMan with Pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367, 1814-1820.
26. Das, K.M.; Lee, E.Y.; Singh, R.; Enani, M.A.; Al Dossari, K.; Van Gorkom, K.; Larsson, S.G.; Langer, R.D. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J. Radiol. Imaging. 2017, 27, 342-349.
27. Al Johani, S.; Hajeer, A.H. MERS-CoV diagnosis: An update. J. Infect. Public Health 2016, 9, 216-219.
28. Centers for Disease Control and Prevention. CDC Laboratory Testing for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Available online: https://www.cdc.gov/coronavirus/mers/lab/lab-testing.html (accessed on 10 July 2019).
29. Bernard-Stoecklin, S.; Nikolay, B.; Assiri, A.; Saeed, A.A.B.; Embarek, P.K.B.; El Bushra, H.; Ki, M.; Rahman Malik, M.; Fontanet, A.; Cauchemez, S.; et al. Comparative analysis of eleven healthcare-associated outbreaks of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from 2015 to 2017. Sci. Rep. 2019, 9, 7385.
30. Memish, Z.A.; Zumia, A.I.; Al-Hakeem, R.F.; Al-Rabeeah, A.A.; Stephens, G.M. Family cluster of Middle East respiratory syndrome coronavirus infections. N. Engl. J. Med. 2013, 368, 2487-2494.
31. Qiu, W.; Chu, C.; Mao, A.; Wu, J. The Impacts on Health, Society, and Economy of SARS and H7N9 Outbreaks in China: A Case Comparison Study. J. Environ. Public Health 2018, 2710185.
32. Memish, Z.A.; Mishra, N.; Olival, K.J.; Fagbo, S.F.; Kapoor, V.; Epstein, J.H.; Alhakeem, R.; Durosinloun, A.; Al Asmari, M.; Islam, A.; et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 2013, 19, 1819-1823.
33. Vergara-Alert, J.; van den Brand, J.M.; Widagdo, W.; Muñoz, M.; Raj, S.; Schipper, D.; Solanes, D.; Cordón, I.; Bensaid, A.; Haagmans, B.L.; et al. Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus. Emerg. Infect. Dis. 2017, 23, 232-240.
34. Elrggal, M.E.; Karami, N.A.; Rafea, B.; Alahmadi, L.; Al Shehri, A.; Alamoudi, R.; Koshak, H.; Alkahtani, S.; Cheema, E. Evaluation of preparedness of healthcare student volunteers against Middle East respiratory syndrome coronavirus (MERS-CoV) in Makkah, Saudi Arabia: A cross-sectional study. Z. Gesundh. Wiss. 2018, 26, 607-612.
35. Kang, C.K.; Song, K.H.; Choe, P.G.; Park, W.B.; Bang, J.H.; Kim, E.S.; Park, S.W.; Kim, H.B.; Kim, N.J.; Cho, S.I.; et al. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J. Korean Med. Sci. 2017, 32, 744-749.
36. Ohnuma, K.; Hatano, R.; Komiya, E.; Otsuka, H.; Itoh, T.; Iwao, N.; Kaneko, Y.; Yamada, T.; Dang, N.H.; Morimoto, C. A novel role for CD26/dipeptidyl peptidase IV as a therapeutic agent. Front. Biosci. 2018, 23, 1754-1779.
37. Eckerle, I.; Müller, M.A.; Kallies, S.; Gotthardt, D.N.; Drosten, C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol. J. 2013, 10, 359.
38. Naskalska, A.; Dabrowska, A.; Nowak, P.; Szczepanski, A.; Jasik, K.; Milewska, A.; Ochman, M.; Zeglen, S.; Rajfur, Z.; Pyrc, K. Novel coronavirus-like particles targeting cells lining the respiratory tract. PLoS ONE 2018, 13, e0203489.
39. Glowacka, I.; Bertram, S.; Herzog, P.; Pfefferle, S.; Steffen, I.; Muench, M.O.; Simmons, G.; Hofmann, H.; Kuri, T.; Weber, F.; et al. Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63. J. Virol. 2010, 84, 1198-1205.
40. Uhal, B.D.; Dang, M.; Dang, V.; Llatos, R.; Cano, E.; Abdul-Hafez, A.; Markey, J.; Piasecki, C.C.; Molina-Molina, M. Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis. J. Virol. 2010, 84, 1198-1205.
41. García-Laorden, M.I.; Lorente, J.A.; Flores, C.; Slutsky, A.S.; Villar, J. Biomarkers for the acute respiratory distress syndrome: How to make the diagnosis more precise. Ann. Transl. Med. 2017, 5, 283.
42. Heymann, D.L.; Rodier, G. Global surveillance, national surveillance, and SARS. Emerg. Infect. Dis. 2004, 10, 173-175.
43. Kim, J.Y.; Song, J.Y.; Yoon, Y.K.; Choi, S.H.; Song, Y.G.; Kim, S.R.; Son, H.J.; Jeong, S.Y.; Choi, J.H.; Kim, K.M.; et al. Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. Infect. Chemother. 2015, 47, 278-302.
44. Park, J.W.; Lee, K.J.; Lee, K.H.; Lee, S.H.; Cho, J.R.; Mo, J.W.; Choi, S.Y.; Kwon, G.Y.; Shin, J.Y.; Hong, J.Y.; et al. Hospital Outbreaks of Middle East Respiratory Syndrome, Daejeon, South Korea, 2015. Emerg. Infect. Dis. 2017, 23, 898-905.
45. Cho, S.Y.; Kang, J.M.; Ha, Y.E.; Park, G.E.; Lee, J.Y.; Kim, J.M.; Jang, C.I.; Jo, I.J.; Ryu, J.G.; Choi, J.R.; et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: An epidemiological outbreak study. Lancet 2016, 388, 994-1001.
46. Korea Centers for Disease Control and Prevention. Middle East Respiratory Syndrome Coronavirus outbreak in the Republic of Korea. Osong Public Health Res. Perspect. 2015, 6, 269-278.
47. Kim, S.W.; Park, J.W.; Jung, H.D.; Yang, J.S.; Park, Y.S.; Lee, C.; Kim, K.M.; Lee, K.J.; Kwon, D.; Hur, Y.J.; et al. Risk factors for transmission of Middle East Respiratory Syndrome Coronavirus infection during the 2015 outbreak in South Korea. Clin. Infect. Dis. 2017, 64, 551-557.
48. European Center for Disease Prevention and Control. Available online: https://www.ecdc.europa.eu/en/newsevents /epidemiological-update-middle-east-respiratory-syndrome-coronavirus-mers-cov-21-july (accessed on 13 February 2019).
49. Majumder, M.S.; Rivers, C.; Lofgren, E.; Fisman, D. Estimation of MERS-Coronavirus Reproductive Number and Case Fatality Rate for the Spring 2014 Saudi Arabia Outbreak: Insights from Publicly Available Data. PLoS Curr. 2014, 6.
50. Oh, M.D.; Park, W.B.; Park, S.W.; Choe, P.G.; Bang, J.H.; Song, K.H.; Kim, E.S.; Kim, H.B.; Kim, N.J. Middle East respiratory syndrome: What we learned from the 2015 outbreak in the Republic of Korea. Korean J. Intern. Med. 2018, 33, 233-246.
51. World Health Organization. Available online: http://www.emro.who.int/pandemic-epidemic-diseases/merscov /mers-situation-update-december-2018.html (accessed on 25 May 2019).
52. Al-Ahmadi, H.; Roland, M. Quality of primary health care in Saudi Arabia: A comprehensive review. Int. J. Qual. Health Care 2005, 17, 331-346.
53. Walston, S.; Al-Harbi, Y.; Al-Omar, B. The changing face of healthcare in Saudi Arabia. Ann. Saudi Med. 2008, 28, 243-250.
54. Taylor, A. The Scary Reason Saudi Famers are Kissing Camels. The Washington Post. Available online: https://www.washingtonpost.com/news/worldviews/wp/2014/05/16/the-scary-reason-saudi-farmersare- kissing-camels/?utm-term=.32ceaf8016c7 (accessed on 10 March 2019).
55. Ajibaili, M. "Saudi Health Minister 'Relieved of His Post'". Al Arabiya. Available online: http://english. alarabiya.net/en/News/middle-east/2014/04/21/Saudi-Health-Minister-relieved-of-duties-.html (accessed on 14 March 2019).
56. Park, K.; Park, J.; Kwon, Y.D.; Kang, Y.; Noh, J.W. Public satisfaction with the healthcare system performance in South Korea: Universal healthcare system. Health Policy 2016, 120, 621-629.
57. Tabekhan, A.K.; Alkhaldi, Y.M.; Alghamdi, A.K. Patients satisfaction with consultation at primary health care centers in Abha City, Saudi Arabia. J. Family Med. Prim. Care 2018, 7, 658-663.
58. Alqahtani, A.S.; Rashid, H.; Basyouni, M.H.; Alhawassi, T.M.; Bin Dhim, N.F. Public response to MERS-CoV in the Middle East: iPhone survey in six countries. J. Infect. Public Health 2017, 10, 534-540.
59. Hemida, M.G.; Elmoslemany, A.; Al-Hizab, F.; Alnaeem, A.; Almathen, F.; Faye, B.; Chu, D.K.W.; Perera, R.A.; Peiris, M. Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Transbound Emerg. Dis. 2018, 64, 344-353.
60. Abrhaley, A.; Leta, S. Medicinal value of camel milk and meat. J. Appl. Anim. Res. 2018, 46.
61. Elzaki Ali, R.M.; Ahmed, S.H.; Al-Mahish, M.A. Camel production in the Kingdom of Saudi Arabia: Economic and environmental impacts. Fundam. Appl. Agric. 2018, 3, 602-608.
62. Park, J.E.; Jung, S.; Kim, A.; Park, J.W. MERS transmission and risk factors: A systemic review. BMB Public Health 2018, 18, 574.
63. Han, H.J.; Liu, J.W.; Yu, H.; Yu, X.J. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection. Viruses 2018, 10, 680.
64. Chong, Y.P.; Song, J.Y.; Seo, Y.B.; Choi, J.P.; Shin, H.S. Rapid Response Team. Antiviral Treatment Guidelines for Middle East Respiratory Syndrome. Infect. Chemother. 2015, 47, 212-222.
65. Haagmans, B.L.; van den Brand, J.M.; Raj, V.S.; Volz, A.; Wohlsein, P.; Smits, S.L.; Schipper, D.; Bestebroer, T.M.; Okba, N.; Fux, R.; et al. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science 2016, 351, 77-81.